Evidence map›Paper›PMID 23144732›Full record

ArticlePloS one2012

The spectrum of cancers in West Africa: associations with human immunodeficiency virus.

Aristophane Tanon, Antoine Jaquet, Didier K Ekouevi, Jocelyn Akakpo, Innocent Adoubi, Isidore Diomande, Fabien Houngbe, Marcel D Zannou, Annie J Sasco, Serge P Eholie and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Trial
  3. Article
  4. Article
  5. Cancer in People with HIV.Infectious disease clinics of North America · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evolving epidemiology of HIV-associated malignancies.Current opinion in HIV and AIDS · 2017
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Aristophane TanonService de Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire.
Antoine Jaquet
Didier K Ekouevi
Jocelyn Akakpo
Innocent Adoubi
Isidore Diomande
Fabien Houngbe
Marcel D Zannou
Annie J Sasco
Serge P Eholie
Francois Dabis
Emmanuel Bissagnene
IeDEA West Africa Collaboration
University Hospital Medical Center at Treichville · CICentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJBordeaux Population Health · FRInserm · FRCentre Hospitalier Universitaire de Cocody · CI

Funding

WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
NIAID NIH HHS 5U01AI069919NIAID NIH HHS U01 AI069919
6 · The paper itself

Abstract

backgroundCancer is a growing co-morbidity among HIV-infected patients worldwide. With the scale-up of antiretroviral therapy (ART) in developing countries, cancer will contribute more and more to the HIV/AIDS disease burden. Our objective was to estimate the association between HIV infection and selected types of cancers among patients hospitalized for diagnosis or treatment of cancer in West Africa.

methodsA case-referent study was conducted in referral hospitals in Côte d'Ivoire and Benin. Each participating clinical ward enrolled all adult patients seeking care for a confirmed diagnosis of cancer and clinicians systematically proposed an HIV test. HIV prevalence was compared between AIDS-defining cancers and a subset of selected non-AIDS defining cancers to a referent group of non-AIDS defining cancers not reported in the literature to be positively or inversely associated with HIV. An unconditional logistic model was used to estimate odds ratios (OR) and their 95% confidence intervals (CI) of the risk of being HIV-infected for selected cancers sites compared to a referent group of other cancers.

resultsThe HIV overall prevalence was 12.3% (CI 10.3-14.4) among the 1,017 cancer cases included. A total of 442 patients constituted the referent group with an HIV prevalence of 4.7% (CI 2.8-6.7). In multivariate analysis, Kaposi sarcoma (OR 62.2 [CI 22.1-175.5]), non-Hodgkin lymphoma (4.0 [CI 2.0-8.0]), cervical cancer (OR 7.9 [CI 3.8-16.7]), anogenital cancer (OR 11.6 [CI 2.9-46.3]) and liver cancer (OR 2.7 [CI 1.1-7.7]) were all associated with HIV infection.

conclusionsIn a time of expanding access to ART, AIDS-defining cancers remain highly associated with HIV infection. This is to our knowledge, the first study reporting a significant association between HIV infection and liver cancer in sub-Saharan Africa.

Indexed as

AdultAnti-Retroviral AgentsBeninCase-Control StudiesComorbidityCote d'IvoireFemaleHIV InfectionsHospitalizationHumansLinear ModelsLiver NeoplasmsLymphoma, Non-HodgkinMaleMiddle AgedMultivariate AnalysisAnti-Retroviral Agents

Identifiers

PMID23144732
PMCPMC3483170
OpenAlexW2039187099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.